Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals
NCT00218309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2017-01-12
Summary
The purpose of this study is to determine whether the opportunity to take free supplemental hydromorphone (HYD) influences drug seeking behavior in heroin dependent individuals.
Conditions
- Heroin Dependence
- Opioid-Related Disorders
Interventions
- DRUG
-
Hydromorphone
Sponsors & Collaborators
-
Wayne State University
collaborator OTHER -
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Mark Greenwald, PhD · Wayne State University
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-09-30
- Completion
- 2005-07-31
Countries
- United States
Study Locations
More Related Trials
-
Improving Treatment and Recovery Services for Individuals With Opioid Problems
NCT05129813 ·Status: UNKNOWN
-
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
NCT00000210 ·Status: COMPLETED ·Phase: PHASE2
-
OUD Smartphone Services
NCT06134882 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Buspirone in Opiate Withdrawal
NCT00326235 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Drug and Risk Behavior Counseling Intervention Among Injecting Drug Users at Opioid Substitution Treatment
NCT03721380 ·Status: COMPLETED ·Phase: NA
-
Contingency Management to Enhance Office-Based Buprenorphine Treatment
NCT04024059 ·Status: COMPLETED ·Phase: NA
-
Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
NCT01723527 ·Status: COMPLETED ·Phase: PHASE1
-
Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder
NCT04712981 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Applying Web Technology to Buprenorphine Treatment
NCT00182598 ·Status: UNKNOWN ·Phase: NA
-
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
NCT00000211 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
NCT05027919 ·Status: RECRUITING ·Phase: PHASE2
-
Dynamic Treatment Regimes for Opioid Use Disorder
NCT07011758 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Pain, Inflammation and Opioid Craving
NCT04190563 ·Status: COMPLETED ·Phase: NA
-
Risks and Benefits of Naloxone Prescribing
NCT02535494 ·Status: COMPLETED ·Phase: NA
-
Using mHealth to Aid Opioid Addicts
NCT01955902 ·Status: COMPLETED
-
Mobile Intervention for Young Opioid Users
NCT03610672 ·Status: UNKNOWN ·Phase: NA
-
Digital Health Intervention to Support Opioid Use Disorder Treatment
NCT03842384 ·Status: COMPLETED ·Phase: NA
-
Contingency Management for Opioid and Stimulant Use Disorders in Primary Care
NCT05288751 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment
NCT01334580 ·Status: COMPLETED ·Phase: PHASE1
-
Incentives to Decrease Opioid Use - Pilot
NCT04235582 ·Status: COMPLETED ·Phase: NA
-
A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment
NCT01416584 ·Status: COMPLETED ·Phase: NA
-
Standard Versus High Dose ED-Initiated Buprenorphine Induction
NCT06494904 ·Status: RECRUITING ·Phase: PHASE3
-
Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
NCT06089707 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Decision Support to Increase Use of Medications for Opioid Use Disorder
NCT06526286 ·Status: NOT_YET_RECRUITING
-
Treating the Partners of Drug Using Pregnant Women: Stage II
NCT00496990 ·Status: COMPLETED ·Phase: PHASE2/PHASE3